97 related articles for article (PubMed ID: 1603482)
1. Recombinant human erythropoietin in the treatment of postpartum anemia.
Huch A; Eichhorn KH; Danko J; Lauener PA; Huch R
Obstet Gynecol; 1992 Jul; 80(1):127-31. PubMed ID: 1603482
[TBL] [Abstract][Full Text] [Related]
2. [Recombinant erythropoietin in autologous blood donation].
von Bormann B; Weidler B; Friedrich M; von Andrian-Werburg H
Anaesthesist; 1991 Jul; 40(7):386-90. PubMed ID: 1928712
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin and intravenous iron therapy in postpartum anaemia.
Wågström E; Akesson A; Van Rooijen M; Larson B; Bremme K
Acta Obstet Gynecol Scand; 2007; 86(8):957-62. PubMed ID: 17653881
[TBL] [Abstract][Full Text] [Related]
4. Iron sucrose with and without recombinant erythropoietin for the treatment of severe postpartum anemia: a prospective, randomized, open-label study.
Krafft A; Breymann C
J Obstet Gynaecol Res; 2011 Feb; 37(2):119-24. PubMed ID: 21159035
[TBL] [Abstract][Full Text] [Related]
5. Hypertension in a pregnancy with renal anemia after recombinant human erythropoietin (rhEPO) therapy.
Kashiwagi M; Breymann C; Huch R; Huch A
Arch Gynecol Obstet; 2002 Nov; 267(1):54-6. PubMed ID: 12410378
[TBL] [Abstract][Full Text] [Related]
6. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
7. rHuEPO in the treatment of postpartum anemia: subcutaneous versus intravenous administration.
Zimmermann R; Breymann C; Huch R; Huch A
Clin Investig; 1994; 72(6 Suppl):S25-30. PubMed ID: 7950168
[TBL] [Abstract][Full Text] [Related]
8. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
[TBL] [Abstract][Full Text] [Related]
9. [Randomized multi-center trial of the administration of erythropoietin in anemia of prematurity].
Javier Manchón G; Natal Pujol A; Coroleu Lletget W; Zuasnábar Cotro A; Badía Barnusell J; Juncá Piera J; Bel Comós J; Sábado Alvarez C; Prats Viñas J
An Esp Pediatr; 1997 Jun; 46(6):587-92. PubMed ID: 9297428
[TBL] [Abstract][Full Text] [Related]
10. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288
[TBL] [Abstract][Full Text] [Related]
11. High doses of recombinant human erythropoietin fail to accelerate platelet reconstitution in allogeneic bone marrow transplantation. Results of a pilot study.
Vannucchi AM; Bosi A; Linari S; Guidi S; Longo G; Lombardini L; Mariani MP; Saccardi R; Laszlo D; Rossi Ferrini P
Haematologica; 1997; 82(1):53-6. PubMed ID: 9107083
[TBL] [Abstract][Full Text] [Related]
12. [Successful treatment of anemia in hemolysis patients using recombinant human erythropoietin. Maintenance dosage and serum concentration].
Stutz B; Rhyner K; Vögtli J; Binswanger U
Schweiz Med Wochenschr; 1987 Sep; 117(38):1397-402. PubMed ID: 3672079
[TBL] [Abstract][Full Text] [Related]
13. Induction of fetal hemoglobin synthesis with recombinant human erythropoietin in anemic patients with heterozygous beta-thalassemia during pregnancy.
Breymann C; Fibach E; Visca E; Huettner C; Huch A; Huch R
J Matern Fetal Med; 1999; 8(1):1-7. PubMed ID: 10052837
[TBL] [Abstract][Full Text] [Related]
14. [Anemia in puerperium; parenteral iron substitution renders erythropoietin therapy dispensable].
Lebrecht A; Häberlin F; Eberhard J
Geburtshilfe Frauenheilkd; 1995 Mar; 55(3):167-70. PubMed ID: 7665066
[TBL] [Abstract][Full Text] [Related]
15. NTP Toxicology and Carcinogenesis Studies of p-Nitrobenzoic Acid (CAS No. 62-23-7) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 442():1-306. PubMed ID: 12595921
[TBL] [Abstract][Full Text] [Related]
16. Monitoring considerations in recombinant human erythropoietin therapy.
Ogden DA
Semin Nephrol; 1989 Mar; 9(1 Suppl 2):12-5. PubMed ID: 2669080
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin treatment of erythropoietin-deficient anemia without renal disease during pregnancy.
Harris SA; Payne G; Putman JM
Obstet Gynecol; 1996 May; 87(5 Pt 2):812-4. PubMed ID: 8677097
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human erythropoietin treatment of postpartum anemia. Preliminary results.
Makrydimas G; Lolis D; Lialios G; Tsiara S; Georgiou I; Bourantas KL
Eur J Obstet Gynecol Reprod Biol; 1998 Oct; 81(1):27-31. PubMed ID: 9846709
[TBL] [Abstract][Full Text] [Related]
19. Correction of anaemia in haemodialysis patients with recombinant human erythropoietin.
Boran M; Dalva I; Yazicioğlu A; Akbay E; Cetin S
Int Urol Nephrol; 1993; 25(2):197-203. PubMed ID: 8365853
[TBL] [Abstract][Full Text] [Related]
20. Effects of recombinant human erythropoietin and interleukin-3 on erythropoietic recovery from acute anemia.
Rosen BS; Levine EA; Egrie JC; Sehgal LR; Greenberg R; Rosen AL; Levine HD; Gould SA
Exp Hematol; 1993 Oct; 21(11):1487-91. PubMed ID: 8405228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
